Algocyte Unveils Portable AI Blood Analyzer for Remote Monitoring
The complete blood count analyzer, cleared for commercial use with UKCA marking, requires a small blood sample comparable to that used by a glucose meter.
Read MorePosted by CLP Edit Staff | Jul 6, 2026 | Hematology Instrumentation |
The complete blood count analyzer, cleared for commercial use with UKCA marking, requires a small blood sample comparable to that used by a glucose meter.
Read MorePosted by CLP Edit Staff | Jun 30, 2026 | Diabetes & Metabolic Diseases, Kidney Disease |
A two-year real-world study of Renalytix’s FDA-approved KidneyIntelX.dkd test showed improved kidney function and targeted treatment in 2,470 patients with type 2 diabetes.
Read MorePosted by CLP Edit Staff | Jun 25, 2026 | Cancer, Diabetes & Metabolic Diseases |
Labcorp studies report new blood-based tools, including the Metabolic Vulnerability Index, may improve risk assessment for MASLD and MASH, offering enhanced prediction of adverse liver outcomes, according to recent peer-reviewed research.
Read MorePosted by CLP Edit Staff | Jun 15, 2026 | Clinical Chemistry, Diabetes & Metabolic Diseases, Immunoassay |
Research suggests that only 12% of men receiving testosterone prescriptions underwent appropriate testing.
Read MorePosted by CLP Edit Staff | May 27, 2026 | Cardiovascular, Company News, Diabetes & Metabolic Diseases |
The new kit uses Tasso+ collection technology and certified laboratory analysis to monitor 17 health markers, including blood sugar and lipid levels.
Read More